Evidence map›Paper›PMID 39679255›Full record

ArticleInternational journal of nanomedicine2024

Cs

Chunyue Wang, Xiaodong Wang, Yuhang Tian, Huimin Tian, Yichi Chen, Bolin Wu, Wen Cheng

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chunyue WangDepartment of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China.ORCID 0000-0002-6358-8134
Xiaodong WangDepartment of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China.ORCID 0000-0002-7887-3421
Yuhang TianDepartment of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China.
Huimin TianDepartment of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China.ORCID 0000-0002-7352-5794
Yichi ChenDepartment of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China.
Bolin WuDepartment of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China.
Wen ChengDepartment of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China.ORCID 0000-0003-4294-9698

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Effective cancer treatment relies on the precise deployment of clinical imaging techniques to accurately treat tumors. One highly representative technology among these is multi-imaging guided phototherapy. This work introduces a new and innovative theranostic drug that combines near-infrared (NIR) irradiation-induced photodynamic therapy (PDT) and photothermal therapy (PTT) to treat malignancies. Moreover, it can be utilized as a contrasting substance for X-ray computed tomography (CT) imaging and contrast-enhanced ultrasound (CEUS) to aid in the administration of therapy. Methods: Cesium tungsten bronze nanobubbles (Cs Results: The Cs Conclusion: Cs

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsPhotochemotherapyAnimalsCell Line, TumorCombined Modality TherapyContrast MediaHep G2 CellsHumansMiceMice, Inbred BALB CMice, NudeNanoparticlesPhotothermal TherapyTheranostic NanomedicineTomography, X-Ray ComputedContrast MediaTungstenTungsten Compoundsapoptosishepatocellular carcinomaimagingphotodynamic therapyphotothermal therapy

Identifiers

PMID39679255
PMCPMC11646368

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.